EziLab supplies the Low Speed Refrigerated Centrifuge EZL-LRC105 for pharmaceutical laboratories that need force between the 11,875 RCF and 18,610 RCF units in this catalog's low speed refrigerated line. Running at 7200rpm and 12,166 RCF with a -20°C to 40°C temperature range, this centrifuge machine occupies a distinct speed point not shared by any other unit in this category, sitting just above the 11,875 RCF model while remaining well below the 18,610 RCF top-tier configuration. That intermediate force level suits pharmaceutical protocols needing separation strength beyond the lower-force units in this line but not approaching the near-high-speed-refrigerated force output the highest tier reaches, giving labs another incremental option across this catalog's low speed refrigerated force progression. The same -20°C to 40°C refrigeration range as the rest of this category keeps temperature-sensitive pharmaceutical samples stable throughout the run. Pharmaceutical labs whose protocols call for this specific intermediate force level, distinct from the other closely-spaced options in this catalog's low speed refrigerated line, get a matched instrument here. See the Centrifuge and Low Speed Refrigerated Centrifuge ranges for intermediate-force refrigerated separation needs across USA pharmaceutical laboratory settings.



Quantity:
$24838
Maximum Speed 7200 rpm
Maximum RCF 12166 × g
Maximum Capacity 6 × 1000 ml
Timer Range 1min to 99h59min; 1s to 99min59s and 1s to 99min59s
Speed Accuracy ±10 rpm
Temperature Range ˗20°C to 40°C
Temperature Accuracy ±1.0°C
Noise Level ≤65dB (A)
Power Consumption 7000 W
Dimensions (L × W × H) 1020 × 870 × 970 mm
Weight 545 kg
  • 7 inch HD screen

  • User-friendly touch interface

  • Motor over heating protection

  • Save up to 2000 user-defined programs

  • Dynamic compressor control (DCC) technology

  • Low Speed Refrigerated Centrifuge EZL-LRC105 is utilized for controlled separation of biological samples at cold temperatures in blood banks, diagnostic labs, clinical research and pharmaceuticals.